US Broker Ratings

Lantheus Holdings (LNTH) Stock Analysis: Navigating a Promising Path with 8% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing opportunity for investors keen on the healthcare sector. Specializing in the development and commercialization of diagnostic and therapeutic products, Lantheus plays a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 16.78% Potential Upside in the Healthcare Sector

Investors with a keen eye on the healthcare sector may find the Stevanato Group S.p.A. (NYSE: STVN) an intriguing prospect, particularly given its 16.78% potential upside. This Italian-based company, with..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Why Analysts See a 23.88% Upside Potential

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to targeting RAS-addicted cancers. As a clinical-stage precision oncology..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 37% Upside with Strong Analyst Confidence

AptarGroup, Inc. (NYSE: ATR) is garnering significant attention from investors, particularly those interested in the healthcare sector. As a leading player in the Medical Instruments & Supplies industry, AptarGroup specializes..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings Signal 50% Upside Potential

Neurocrine Biosciences, Inc. (NBIX), a prominent player within the healthcare sector, stands out in the specialty and generic drug manufacturing industry. With a market capitalization of $14.07 billion, this San..

ResMed Inc. (RMD) Stock Analysis: Evaluating a 12.71% Upside in the Digital Health Arena

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is making waves with its innovative digital health and cloud-connected medical devices. Based in the United States and with..

Legend Biotech Corporation (LEGN): Analyst Consensus Points to a Remarkable 145% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with its promising potential for substantial returns. Operating within the highly dynamic biotechnology sector, this Somerset, New Jersey-based company specializes in..

Align Technology, Inc. (ALGN) Stock Analysis: Unveiling a 40.59% Potential Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN), a major player in the healthcare sector, specifically within the medical instruments and supplies industry, is making waves among investors. With a market cap of..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 30.99% Potential Upside in the Eye Care Industry

Investors with a keen eye on the healthcare sector might find Alcon Inc. (NYSE: ALC) an intriguing addition to their portfolios. With a market capitalization of $31.16 billion, this Switzerland-based..

The Ensign Group, Inc. (ENSG) Stock Analysis: A 25% Upside Opportunity in Healthcare’s Resilient Player

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a formidable force in the healthcare sector, specifically within the Medical Care Facilities industry. With a current market capitalization of $10.21..

Integer Holdings Corporation (ITGR) Stock Analysis: Evaluating the Medical Device Giant’s Valuation and Growth Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the medical device industry. With a market capitalization of $4.3 billion, Integer operates as a contract..

Cardinal Health (CAH) Stock Analysis: Robust Growth and Strong Buy Ratings Signal a Promising Investment

Cardinal Health, Inc. (CAH), a stalwart in the healthcare sector, continues to capture investor attention with its robust market cap of $50.99 billion and a strategic position in the medical..

Qiagen N.V. (QGEN) Stock Analysis: Evaluating Its Potential with a 4.72% Upside

Investors looking for opportunities in the healthcare sector should give Qiagen N.V. (NYSE: QGEN) a closer look. With its roots deeply entrenched in the diagnostics and research industry, this Netherlands-based..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention with its substantial potential upside, rated at a remarkable 81.24%. This New Jersey-based biopharmaceutical..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Unveiling a 45% Potential Upside in the Healthcare Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading biotech company in the healthcare sector, is capturing investor attention with its impressive growth potential and a compelling 45.08% potential upside, according to..

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings and Robust Growth Potential

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing for animals. With a market..

Revvity, Inc. (RVTY) Stock Analysis: Evaluating the Potential Amidst a 0% Price Change

Revvity, Inc. (NASDAQ: RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing investor attention lately. With a market capitalization of $16.86 billion, the..

Henry Schein, Inc. (HSIC) Stock Analysis: Evaluating Growth Potential with a 12.62% Upside

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector specializing in medical distribution, is drawing investor attention with its substantial market capitalization of $9.84 billion. As a..

GSK plc (GSK) Stock Analysis: Healthcare Giant Offers 20.99% Potential Upside

For individual investors eyeing opportunities in the healthcare sector, GSK plc (GSK) presents a compelling case. With a market capitalization of $98.62 billion, this UK-based pharmaceutical titan engages in the..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 23.90% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a formidable player in the healthcare sector, specifically in medical care facilities, presents an intriguing investment opportunity with a notable potential upside of 23.90%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds